0001104659-21-130022.txt : 20211026 0001104659-21-130022.hdr.sgml : 20211026 20211026170105 ACCESSION NUMBER: 0001104659-21-130022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211026 FILED AS OF DATE: 20211026 DATE AS OF CHANGE: 20211026 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clancy Paul J CENTRAL INDEX KEY: 0001409601 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 211349378 MAIL ADDRESS: STREET 1: C/O BIOGEN IDEC INC. STREET 2: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 tm2130646-19_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-10-26 0 0001840233 Xilio Therapeutics, Inc. XLO 0001409601 Clancy Paul J C/O XILIO THERAPEUTICS, INC. 828 WINTER STREET, SUITE 300 WALTHAM MA 02451 1 0 0 0 Stock Option (right to buy) 5.51 2021-10-26 4 A 0 44033 0.00 A 2030-07-22 Common Stock 44033 44033 D Stock Option (right to buy) 5.89 2021-10-26 4 A 0 65528 0.00 A 2021-03-10 Common Stock 65528 65528 D On July 23, 2020, the reporting person was granted an option to purchase 44,033 shares of common stock of the Company, the vesting of which was contingent upon the closing of the Company's initial public offering ("IPO"). The Company's IPO closed as of October 26, 2021. On October 26, 2021, 13,760 shares underlying the award vested and the remainder will vest in equal monthly installments until July 16, 2024. On March 11, 2021, the reporting person was granted an option to purchase 65,528 shares of common stock of the Company, the vesting of which was contingent upon the closing of the Company's IPO. The Company's IPO closed as of October 26, 2021. On October 26, 2021, 20,477 shares underlying the option vested and the remainder will vest in equal monthly installments until July 16, 2024. /s/ Chris Frankenfield attorney-in-fact for Paul Clancy 2021-10-25